Generic placeholder image

Current Pharmaceutical Design

Author(s): Samuele Laudani, Federica Martina Di Domenico, Nadia Paladino, Ida Guerrera, Giuseppe Grosso* and Justyna Godos

DOI: 10.2174/1381612829666230726112255

DownloadDownload PDF Flyer Cite As
Curcumin Supplementation and Vascular Health: Is Gut Microbiota Involved?

Page: [1971 - 1974] Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Curcumin is a polyphenol compound widely investigated for its potential health benefits. Clinical evidence from randomized controlled trials shows substantial positive effects in healthy individuals but contrasting results for patients with cardio-metabolic disorders. There is growing evidence that the gut microbiota may play a role in curcumin transformation and absorption of more bioactive compounds, suggesting that the baseline health status (or other unmeasured variables) may explain the observed variability of the results.

[1]
Micek A, Godos J, Del Rio D, Galvano F, Grosso G. Dietary flavonoids and cardiovascular disease: A comprehensive dose–response meta‐analysis. Mol Nutr Food Res 2021; 65(6): 2001019.
[http://dx.doi.org/10.1002/mnfr.202001019] [PMID: 33559970]
[2]
Grosso G, Micek A, Godos J, et al. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: Systematic review and dose-response meta-analysis. Am J Epidemiol 2017; 185(12): 1304-16.
[http://dx.doi.org/10.1093/aje/kww207] [PMID: 28472215]
[3]
Godos J, Vitale M, Micek A, et al. Dietary polyphenol intake, blood pressure, and hypertension: A systematic review and meta-analysis of observational studies. Antioxidants 2019; 8(6): 152.
[http://dx.doi.org/10.3390/antiox8060152] [PMID: 31159186]
[4]
Li KX, Wang ZC, Machuki JOA, et al. Benefits of curcumin in the vasculature: A therapeutic candidate for vascular remodeling in arterial hypertension and pulmonary arterial hypertension? Front Physiol 2022; 13: 848867.
[http://dx.doi.org/10.3389/fphys.2022.848867] [PMID: 35530510]
[5]
Singh L, Sharma S, Xu S, Tewari D, Fang J. Curcumin as a natural remedy for atherosclerosis: A pharmacological review. Molecules 2021; 26(13): 4036.
[http://dx.doi.org/10.3390/molecules26134036] [PMID: 34279384]
[6]
Li H, Sureda A, Devkota HP, et al. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv 2020; 38: 107343.
[http://dx.doi.org/10.1016/j.biotechadv.2019.01.010] [PMID: 30716389]
[7]
Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Curcumin in metabolic health and disease. Nutrients 2021; 13(12): 4440.
[http://dx.doi.org/10.3390/nu13124440] [PMID: 34959992]
[8]
Salehi B, Del Prado-Audelo ML, Cortés H, et al. Therapeutic applications of curcumin nanomedicine formulations in cardiovascular diseases. J Clin Med 2020; 9(3): 746.
[http://dx.doi.org/10.3390/jcm9030746] [PMID: 32164244]
[9]
Monfoulet LE, Mercier S, Bayle D, et al. Curcumin modulates endothelial permeability and monocyte transendothelial migration by affecting endothelial cell dynamics. Free Radic Biol Med 2017; 112: 109-20.
[http://dx.doi.org/10.1016/j.freeradbiomed.2017.07.019] [PMID: 28739530]
[10]
McCubrey JA, Lertpiriyapong K, Steelman LS, et al. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY) 2017; 9(6): 1477-536.
[http://dx.doi.org/10.18632/aging.101250] [PMID: 28611316]
[11]
Karimian MS, Pirro M, Johnston TP, Majeed M, Sahebkar A. Curcumin and endothelial function: Evidence and mechanisms of protective effects. Curr Pharm Des 2017; 23(17): 2462-73.
[PMID: 28228072]
[12]
Lin X, Liu MH, Hu HJ, et al. Curcumin enhanced cholesterol efflux by upregulating ABCA1 expression through AMPK-SIRT1-LXRα signaling in THP-1 macrophage-derived foam cells. DNA Cell Biol 2015; 34(9): 561-72.
[http://dx.doi.org/10.1089/dna.2015.2866] [PMID: 26102194]
[13]
Pourbagher-Shahri AM, Farkhondeh T, Ashrafizadeh M, Talebi M, Samargahndian S. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades. Biomed Pharmacother 2021; 136: 111214.
[http://dx.doi.org/10.1016/j.biopha.2020.111214] [PMID: 33450488]
[14]
Shao J, Han J, Zhu Y, et al. Curcumin induces endothelium-dependent relaxation by activating endothelial TRPV4 channels. J Cardiovasc Transl Res 2019; 12(6): 600-7.
[http://dx.doi.org/10.1007/s12265-019-09928-8] [PMID: 31664615]
[15]
Akazawa N, Choi Y, Miyaki A, et al. Effects of curcumin intake and aerobic exercise training on arterial compliance in postmenopausal women. Artery Res 2012; 7(1): 67.
[http://dx.doi.org/10.1016/j.artres.2012.09.003]
[16]
Santos-Parker JR, Strahler TR, Bassett CJ, Bispham NZ, Chonchol MB, Seals DR. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging (Albany NY) 2017; 9(1): 187-208.
[http://dx.doi.org/10.18632/aging.101149] [PMID: 28070018]
[17]
Alidadi M, Sahebkar A, Eslami S, et al. The effect of curcumin supplementation on pulse wave velocity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Adv Exp Med Biol 2021; 1308: 1-11.
[http://dx.doi.org/10.1007/978-3-030-64872-5_1] [PMID: 33861432]
[18]
Bateni Z, Rahimi HR, Hedayati M, Afsharian S, Goudarzi R, Sohrab G. The effects of nano‐curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double‐blind clinical trial. Phytother Res 2021; 35(7): 3945-53.
[http://dx.doi.org/10.1002/ptr.7109] [PMID: 33851448]
[19]
Saberi-Karimian M, Parizadeh SMR, Ghayour-Mobarhan M, et al. Evaluation of the effects of curcumin in patients with metabolic syndrome. Comp Clin Pathol 2018; 27(3): 555-63.
[http://dx.doi.org/10.1007/s00580-017-2624-y]
[20]
Sangouni AA, Taghdir M, Mirahmadi J, Sepandi M, Parastouei K. Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial. Nutr J 2022; 21(1): 62.
[http://dx.doi.org/10.1186/s12937-022-00816-7] [PMID: 36192751]
[21]
Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, et al. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial. Nutr Metab 2019; 16(1): 8.
[http://dx.doi.org/10.1186/s12986-019-0331-1] [PMID: 30705687]
[22]
Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Curcumin and its potential impact on microbiota. Nutrients 2021; 13(6): 2004.
[http://dx.doi.org/10.3390/nu13062004] [PMID: 34200819]
[23]
Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-94.
[http://dx.doi.org/10.3748/wjg.v20.i43.16079] [PMID: 25473159]
[24]
Kim MH, Yun KE, Kim J, et al. Gut microbiota and metabolic health among overweight and obese individuals. Sci Rep 2020; 10(1): 19417.
[http://dx.doi.org/10.1038/s41598-020-76474-8] [PMID: 33173145]
[25]
Di Meo F, Margarucci S, Galderisi U, Crispi S, Peluso G. Curcumin, gut microbiota, and neuroprotection. Nutrients 2019; 11(10): 2426.
[http://dx.doi.org/10.3390/nu11102426] [PMID: 31614630]
[26]
Nakmareong S, Kukongviriyapan U, Pakdeechote P, et al. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res 2012; 35(4): 418-25.
[http://dx.doi.org/10.1038/hr.2011.180] [PMID: 22072109]
[27]
Chen X, Xie Q, Zhu Y, et al. Cardio-protective effect of tetrahydrocurcumin, the primary hydrogenated metabolite of curcumin in vivo and in vitro: Induction of apoptosis and autophagy via PI3K/AKT/mTOR pathways. Eur J Pharmacol 2021; 911: 174495.
[http://dx.doi.org/10.1016/j.ejphar.2021.174495] [PMID: 34555398]
[28]
Scazzocchio B, Minghetti L, D’Archivio M. Interaction between gut microbiota and curcumin: A new key of understanding for the health effects of curcumin. Nutrients 2020; 12(9): 2499.
[http://dx.doi.org/10.3390/nu12092499] [PMID: 32824993]
[29]
Vamanu E, Gatea F, Sârbu I, Pelinescu D. An in vitro study of the influence of curcuma longa extracts on the microbiota modulation process, in patients with hypertension. Pharmaceutics 2019; 11(4): 191.
[http://dx.doi.org/10.3390/pharmaceutics11040191] [PMID: 31003502]
[30]
Li HB, Xu ML, Du MM, et al. Curcumin ameliorates hypertension via gut-brain communication in spontaneously hypertensive rat. Toxicol Appl Pharmacol 2021; 429: 115701.
[http://dx.doi.org/10.1016/j.taap.2021.115701] [PMID: 34453990]
[31]
Evans LW, Athukorala M, Martinez-Guryn K, Ferguson BS. The role of histone acetylation and the microbiome in phytochemical efficacy for cardiovascular diseases. Int J Mol Sci 2020; 21(11): 4006.
[http://dx.doi.org/10.3390/ijms21114006] [PMID: 32503339]
[32]
Chen Y, Du J, Zhao YT, et al. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol 2015; 14(1): 99.
[http://dx.doi.org/10.1186/s12933-015-0262-8] [PMID: 26245924]
[33]
Zhang L, Du J, Yano N, et al. Sodium butyrate protects against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice. J Cell Biochem 2017; 118(8): 2395-408.
[http://dx.doi.org/10.1002/jcb.25902] [PMID: 28109123]
[34]
Patel BM. Sodium butyrate controls cardiac hypertrophy in experimental models of rats. Cardiovasc Toxicol 2018; 18(1): 1-8.
[http://dx.doi.org/10.1007/s12012-017-9406-2] [PMID: 28389765]